| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 130,1 k € | +3.9% | 125,2 k € | +16.4% | 107,6 k € | +14.4% | 94,1 k € | +6.3% | 88,5 k € | +16.9% | 75,7 k € | +29.6% | 58,4 k € | +40.0% | 41,7 k € | +47.2% | 28,4 k € | -51.2% | 58,1 k € | +19.5% | 48,7 k € | +11.7% | 43,6 k € | -18.6% | 53,6 k € | |
| EBITDA | 120,6 k € | +3.9% | 116,0 k € | +69.9% | 68,3 k € | -22.4% | 88,0 k € | +8.1% | 81,4 k € | +20.4% | 67,5 k € | +28.7% | 52,5 k € | +43.5% | 36,6 k € | +54.1% | 23,7 k € | -29.8% | 33,8 k € | -24.9% | 45,0 k € | +12.8% | 39,9 k € | -21.5% | 50,8 k € | |
| Operating profit | 52,5 k € | +5.4% | 49,8 k € | +200.4% | -49,6 k € | -243.5% | 34,6 k € | +24.6% | 27,8 k € | +96.9% | 14,1 k € | +27694.9% | -51,1 € | +99.2% | -6,5 k € | +22.4% | -8,4 k € | -265.3% | 5,1 k € | -76.7% | 21,7 k € | +21.4% | 17,9 k € | -54.8% | 39,5 k € | |
| Profit/loss | 26,7 k € | -17.5% | 32,4 k € | +149.8% | -65,0 k € | -279.9% | 36,1 k € | +23.5% | 29,3 k € | +100.5% | 14,6 k € | +1003.5% | 1,3 k € | +127.1% | -4,9 k € | -108.2% | 59,4 k € | +547.8% | 9,2 k € | -62.8% | 24,7 k € | -95.0% | 493,6 k € | +1412.8% | 32,6 k € | |
| Equity | 1,4 M € | +1.9% | 1,4 M € | +2.4% | 1,3 M € | -4.6% | 1,4 M € | +2.6% | 1,4 M € | +2.2% | 1,3 M € | +1.1% | 1,3 M € | +0.1% | 1,3 M € | -0.4% | 1,3 M € | +4.7% | 1,3 M € | +0.7% | 1,3 M € | +2.0% | 1,2 M € | +66.7% | 739,9 k € | |
| Total assets | 2,4 M € | -2.1% | 2,5 M € | -2.1% | 2,5 M € | +26.8% | 2,0 M € | -0.4% | 2,0 M € | -1.9% | 2,0 M € | -1.7% | 2,1 M € | +5.7% | 1,9 M € | +13.0% | 1,7 M € | +10.5% | 1,6 M € | -1.1% | 1,6 M € | +0.9% | 1,6 M € | +86.4% | 839,3 k € | |
| Cash | 6,6 k € | -17.6% | 8,0 k € | +72.0% | 4,7 k € | -92.4% | 61,0 k € | +283.2% | 15,9 k € | +704.1% | 2,0 k € | -73.6% | 7,5 k € | -94.5% | 135,6 k € | -38.5% | 220,3 k € | +75.2% | 125,8 k € | -71.5% | 442,0 k € | +2.3% | 432,1 k € | +9493.3% | 4,5 k € | |
| Debts | 875,6 k € | -7.2% | 943,9 k € | -8.0% | 1,0 M € | +141.2% | 425,1 k € | -8.2% | 463,2 k € | -11.7% | 524,7 k € | -7.7% | 568,1 k € | +27.5% | 445,6 k € | +106.2% | 216,1 k € | +440.9% | 39,9 k € | -35.5% | 61,9 k € | -9.9% | 68,7 k € | -19.7% | 85,6 k € | |
Private limited company · Bruxelles · incorporated on 28/06/2011
Private limited company profitable and well capitalised. Cash position declining (-17.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Castelein Clinical Projects and Operations is a Private limited company incorporated in 2011. Its registered office is in Bruxelles.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette